Meet the Team
Bernadette Porter MBE
CEO & Clinical Lead,
Bernadette has received many awards including an MBE for services to nursing, the inaugural HSJ top 50 NHS Innovators List and E health Nurse for the UK in 2014.
Dr Carmel Curtis
Consultant in clinical
Digital Advisor & Operational Lead
Specialist Advisory Board
Dr Robert Brenner
Dr Brenner has been involved in the co-design of the NeuroResponse model contributing to the benchmark audit of Multiple Sclerosis service across the UCL partner region and the patient and family co-design events.
Prof Jeremy Chataway
He has a particular interest in advanced clinical trial design in Progressive MS and was the Chief Investigator (CI) of the MS-STAT1 trial in secondary progressive MS, using high dose simvastatin; and is the CI of the MS-SMART (recently published*) and MS-STAT2 (still recruiting) trials in secondary progressive MS. He was until recently the Clinical Director of the UCL Comprehensive Clinical Trials Unit and works closely with the MRC Clinical Trials Unit and the UK MS Society. Separately, he was a Founder member of the Queen Square Adult Onset Leukodystrophy Group, studying rare white matter disorders.
*MS-SMART trial: Lancet Neurology Jan 2020 https://doi.org/10.1016/S1474-4422(19)30485-5
In 2017, Blu was appointed Director of Operations for a London provider of Integrated Urgent Care services providing care to 2.3 million people across North Central and North West London. In this role, Blu oversees multi-disciplinary teams to deliver a service portfolio of £25mn annually; developing strategies to innovate and deliver improvements to patient services.